Literature DB >> 23710296

Refractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compound.

Zaifang Yu1, Jarrod D Predina, Guanjun Cheng.   

Abstract

AIM: To explore the possibility that nucleotide oligomerization domain 1 (NOD1) pathway involved in refractoriness of interferon-β signaling in mouse respiratory epithelial cells induced by the anticancer xanthone compound, 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
METHODS: C10 mouse bronchial epithelial cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mmol/L glutamine, 100 units/mL penicillin, 100 g/mL streptomycin. Pathogen-free female BALB/c mice were used to explore the mechanisms of refractoriness of interferon-signaling. Mouse thioglycollate-elicited peritoneal macrophages, bone marrow derived macrophages and bone marrow derived dendritic cells were collected and cultured. The amount of interferon (IFN)-inducible protein-10 (IP10/CXCL10), macrophage chemotactic protein (MCP1/CCL2) and interleukin (IL)-6 secreted by cells activated by DMXAA was quantified using enzyme-linked immunosorbent assay kits according to the instructions of the manufacturers. Total RNA was isolated from cells or nasal epithelium with RNeasy Plus Mini Kit, and cDNA was synthesized. Gene expression was checked using Applied Biosystems StepOne Real-Time Polymerase Chain Reaction System. Transfection of small interfering RNA (siRNA) control, NOD1 duplexed RNA oligonucleotides, and high-mobility group box 1/2/3 (HMGB1/2/3) siRNA was performed using siRNA transfection reagent.
RESULTS: DMXAA activates IFN-β pathway with high level of IFN-β dependent antiviral genes including 2', 5'-oligoadenylate synthetase 1 and myxovirus resistance 1 in mouse thioglycollate-elicited peritoneal macrophages, bone marrow derived macrophages and bone marrow derived dendritic cells. Activation of IFN-β by DMXAA involved in NOD1, but not HMGB1/2/3 signal pathway demonstrated by siRNA. NOD1 pathway plays an important role in refractoriness of IFN-β signaling induced by DMXAA in mouse C10 respiratory epithelial cells and BALB/c mice nasal epithelia. These data indicate that DMXAA is not well adapted to the intrinsic properties of IFN-β signaling. Approaches to restore sensitivity of IFN-β signaling by find other xanthone compounds may function similarly, could enhance the efficacy of protection from influenza pneumonia and potentially in other respiratory viral infections.
CONCLUSION: NOD1 pathway may play an important role in refractoriness of IFN-β signaling in mouse respiratory epithelial cells induced by DMXAA.

Entities:  

Keywords:  Bronchial epithelium; Innate immunity; Interferon; Refractoriness; Xanthone

Year:  2013        PMID: 23710296      PMCID: PMC3652647          DOI: 10.4331/wjbc.v4.i2.18

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  32 in total

1.  Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98.

Authors:  J P Rodrigues; D Sitterlin; A Bachi; X Wu; M Wilm; M Carmo-Fonseca; E Izaurralde
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

2.  Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.

Authors:  Cristian Cilloniz; Mary J Pantin-Jackwood; Chester Ni; Alan G Goodman; Xinxia Peng; Sean C Proll; Victoria S Carter; Elizabeth R Rosenzweig; Kristy J Szretter; Jacqueline M Katz; Marcus J Korth; David E Swayne; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 3.  The host type I interferon response to viral and bacterial infections.

Authors:  Andrea K Perry; Gang Chen; Dahai Zheng; Hong Tang; Genhong Cheng
Journal:  Cell Res       Date:  2005-06       Impact factor: 25.617

4.  Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.

Authors:  Magdalena Sarasin-Filipowicz; Xueya Wang; Ming Yan; Francois H T Duong; Valeria Poli; Douglas J Hilton; Dong-Er Zhang; Markus H Heim
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 5.  Mechanisms of interferon mediated anti-viral resistance.

Authors:  C J Clarke; J A Trapani; R W Johnstone
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2001-08

6.  Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.

Authors:  Arminder S Jassar; Eiji Suzuki; Veena Kapoor; Jing Sun; Michael B Silverberg; Lumei Cheung; Marie D Burdick; Robert M Strieter; Lai-Ming Ching; Larry R Kaiser; Steven M Albelda
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

7.  The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Authors:  Seth G Thacker; Celine C Berthier; Deborah Mattinzoli; Maria Pia Rastaldi; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

8.  Role for platelet-endothelial cell adhesion molecule-1 in macrophage Fcgamma receptor function.

Authors:  Steven M Albelda; Kelvin C Lau; Paul Chien; Zhen-Yu Huang; Eugenia Arguiris; Alyssa Bohen; Jing Sun; Jessica A Billet; Melpo Christofidou-Solomidou; Zena K Indik; Alan D Schreiber
Journal:  Am J Respir Cell Mol Biol       Date:  2004-04-15       Impact factor: 6.914

Review 9.  Rotavirus and reovirus modulation of the interferon response.

Authors:  Barbara Sherry
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

10.  Stimulator of IFN gene is critical for induction of IFN-beta during Chlamydia muridarum infection.

Authors:  Daniel Prantner; Toni Darville; Uma M Nagarajan
Journal:  J Immunol       Date:  2010-01-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.